TY - JOUR
T1 - Effects of high altitude and water deprivation on arginine vasopressin release in men
AU - Maresh, C. M.
AU - Kraemer, W. J.
AU - Judelson, D. A.
AU - VanHeest, J. L.
AU - Trad, L.
AU - Kulikowich, J. M.
AU - Goetz, K. L.
AU - Cymerman, A.
AU - Hamilton, A. J.
PY - 2004/1
Y1 - 2004/1
N2 - High-altitude exposure changes the distribution of body water and electrolytes. Arginine vasopressin (AVP) may influence these alterations. The purpose of this study was to examine the effect of a 24-h water deprivation trial (WDT) on AVP release after differing altitude exposures. Seven healthy males (age 22 ± 1 yr, height 176 ± 2 cm, mass 75.3 ± 1.8 kg) completed three WDTs: at sea level (SL), after acute altitude exposure (2 days) to 4,300 m (AA), and after prolonged altitude exposure (20 days) to 4,300 m (PA). Body mass, standing and supine blood pressures, plasma osmolality (Posm), and plasma AVP (PAVP) were measured at 0, 12, 16, and 24 h of each WDT. Urine volume was measured at each void throughout testing. Baseline Posm increased from SL to altitude (SL 291.7 ± 0.8 mosmol/kgH2O, AA 299.6 ± 2.2 mosmol/kgH2O, PA 302. 3 ± 1.5 mosmol/kgH20, P < 0.05); however, baseline PAVP measurements were similar. Despite similar Posm values, the maximal PAvP response during the WDT (at 16 h) was greater at altitude than at SL (SL 1.7 ± 0.5 pg/ml, AA 6.4 ± 0.7 pg/ml, PA 8.7 ± 0. 9 pg/ml, P < 0.05). In conclusion, hypoxia appeared to alter AVP regulation by raising the osmotic threshold and increasing AVP responsiveness above that threshold.
AB - High-altitude exposure changes the distribution of body water and electrolytes. Arginine vasopressin (AVP) may influence these alterations. The purpose of this study was to examine the effect of a 24-h water deprivation trial (WDT) on AVP release after differing altitude exposures. Seven healthy males (age 22 ± 1 yr, height 176 ± 2 cm, mass 75.3 ± 1.8 kg) completed three WDTs: at sea level (SL), after acute altitude exposure (2 days) to 4,300 m (AA), and after prolonged altitude exposure (20 days) to 4,300 m (PA). Body mass, standing and supine blood pressures, plasma osmolality (Posm), and plasma AVP (PAVP) were measured at 0, 12, 16, and 24 h of each WDT. Urine volume was measured at each void throughout testing. Baseline Posm increased from SL to altitude (SL 291.7 ± 0.8 mosmol/kgH2O, AA 299.6 ± 2.2 mosmol/kgH2O, PA 302. 3 ± 1.5 mosmol/kgH20, P < 0.05); however, baseline PAVP measurements were similar. Despite similar Posm values, the maximal PAvP response during the WDT (at 16 h) was greater at altitude than at SL (SL 1.7 ± 0.5 pg/ml, AA 6.4 ± 0.7 pg/ml, PA 8.7 ± 0. 9 pg/ml, P < 0.05). In conclusion, hypoxia appeared to alter AVP regulation by raising the osmotic threshold and increasing AVP responsiveness above that threshold.
KW - Acute mountain sickness
KW - Antidiuretic hormone
KW - Dehydration
KW - Fluid regulation
KW - Osmotic threshold
UR - https://www.scopus.com/pages/publications/0346787542
UR - https://www.scopus.com/pages/publications/0346787542#tab=citedBy
U2 - 10.1152/ajpendo.00332.2003
DO - 10.1152/ajpendo.00332.2003
M3 - Article
C2 - 12954599
AN - SCOPUS:0346787542
SN - 0193-1849
VL - 286
SP - E20-E24
JO - American Journal of Physiology - Endocrinology and Metabolism
JF - American Journal of Physiology - Endocrinology and Metabolism
IS - 1 49-1
ER -